Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.9.4619

Is Level V Dissection Necessary for Low-risk Patients with Papillary Thyroid Cancer Metastasis in Lateral Neck Levels II, III, and IV  

Yu, Wen-Bin (Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck, Peking University Cancer Hospital & Institute)
Tao, Song-Yun (Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck, Peking University Cancer Hospital & Institute)
Zhang, Nai-Song (Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck, Peking University Cancer Hospital & Institute)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.9, 2012 , pp. 4619-4622 More about this Journal
Abstract
Whether it is beneficial to dissect level V in papillary thyroid cancer (PTC) patients with positive lateral neck lymph nodes at levels II-IV is still controversial, especially for low risk cases. In this study, we reviewed the medical records of 47 patients who underwent 47 ipsilateral selective lateral neck dissections (levels II-IV) for previously untreated papillary thyroid carcinomas between October 2006 and October 2008 to assist in establishing the optimal strategy for lateral neck dissection in low risk PTC patients with clinically negative level V nodes. All 47 patients were confirmed to have positive lymph nodes pathologically. Seventeen (36.12%), 36 (76.6%), and 34 (72.34%) patients had positive lymph nodes in levels II, III, and IV, respectively. The mean number of pathologically positive lymph nodes was 1.7 in level II, 2.9 in level III, 2.8 in level IV. No death and distant metastasis were recorded during follow up period. Just 2 patients exhibited recurrence to lymph nodes, and only one showed nodal recurrence in ipsilateral level V, who had positive lymph nodes in all of levels II, III, and IV at initial neck surgery. In conclusion, for PTC low risk patients with clinically negative lymph nodes in level V, non-performance of level V dissection would still achieve good survival results as traditional modified radical neck dissection, with a "wait and see" strategy to be recommended.
Keywords
Papillary cancer; lymph node dissection level V; thyroid;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bhattacharyya N (2003). Surgical treatment of cervical nodal metastases in patients with papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg, 129, 1101-4.   DOI   ScienceOn
2 Cappiello J, Piazza C, Giudice M, De Maria G (2005) Nicolai P: Shoulder disability after different selective neck dissections (levels II-IV versus levels II-V): a comparative study. Laryngoscope, 115, 259-63.   DOI
3 Caron NR, Clark OH (2005) Papillary thyroid cancer: surgical management of lymph node metastases. Curr Treat Options Oncol, 6, 311-22.   DOI   ScienceOn
4 Caron NR, Tan YY, Ogilvie JB, et al (2006)Selective modified radical neck dissection for papillary thyroid cancer-is level I, II, and V dissection always necessary? World J Surg, 30, 833-40.   DOI   ScienceOn
5 Lundgren CI, Hall P, Dickman PW, Zedenius J (2006). Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.. Cancer, 106, 524-31.   DOI
6 Machens A, Hinze R, Thomusch O, Dralle H (2002). Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg, 26, 22-8.   DOI   ScienceOn
7 Moley J , Wells S (1999). Compartment-mediated dissection for papillary thyroid cancer. Langenbecks Arch Surg 384, 9-15.   DOI
8 Noguchi S, Murakami N (1987). The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am, 67, 251-61.
9 Robbins KT, Clayman G, Levine PA (2002). Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery. Arch Otolaryngol Head Neck Surg, 128, 751-8.   DOI   ScienceOn
10 Roh JL, Kim JM , Park CI (2008). Lateral Cervical Lymph Node Metastases from Papillary Thyroid Carcinoma: Pattern of Nodal Metastases and Optimal Strategy for Neck Dissection. Ann Surg Oncol, 15, 1177-82.   DOI
11 Sato N, Oyamatsu M, Koyama Y, et al (1998). Do the level of nodal disease according to the TNM classification and the number of involved cervical nodes reflect prognosis in patients with differentiated carcinoma of the thyroid gland? J Surg Oncol, 69, 151-5.   DOI
12 Shaha AR, Shah JP, Loree TR (1996). Patterns of nodal and distant metastasis based on histologic varieties in differentiated carcinoma of the thyroid. Am J Surg, 172, 692-4.   DOI   ScienceOn
13 Shaha A (2006) Treatment of thyroid cancer based on risk groups. J Surg Oncol, 94, 683-91.   DOI   ScienceOn
14 Inoue H, Nibu K, Saito M, et al (2006). Quality of life after neck dissection. Arch Otolaryngol Head Neck Surg, 132, 662-6.   DOI   ScienceOn
15 Cooper DS, Doherty GM, Haugen BR, et al (2006). Management guidelines for patients with thyroid nodules and differatiated thyroid carlcer. Thyroid, 16, 109-42.   DOI   ScienceOn
16 Davies L, Welch HG (2006). Increasing incidence of thyroid cancer in the United States, 1973-2002. Jama, 295, 2164-7.   DOI   ScienceOn
17 Doherty GM, Haugen BR, Kloos RT, et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19, 1167-214.   DOI   ScienceOn
18 Ito Y, Tomoda C, Uruno T, et al (2005). Ultrasound-detectable and anatomopathologically-detectable node metastasis in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg, 29, 917-20.   DOI
19 Ito Y, Miyauchi A, Jikuzono T, et al (2007)Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg, 31, 838-48.   DOI   ScienceOn
20 Ito Y, Tsushima Y, Masuoka H, et al (2011) Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1- 3.0 cm: first report of a trial at Kuma Hospital. Surg Today, 41, 1486-91.   DOI
21 Kupferman ME, Weinstock YE, Santillan AA, et al (2008) Predictors of level V metastasis in well-differentiated thyroid cancer. Head Neck, 30, 1469-74.   DOI   ScienceOn
22 Laverick S, Lowe D, Brown JS, et al (2004). The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg, 130, 149-54.   DOI
23 Terrell JE, Welsh DE, Bradford CR, et al (2000). Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope, 110, 620-6.   DOI   ScienceOn
24 Shaha A(2006) Selective Surgical Management of well- Differentiated Thyroid Cancer. Ann N Y Acad Sci, 1138, 58-64.
25 Sivanandan R , Soo KC (2001). Pattern of cervical lymph node metastases from papillary carcinoma of the thyroid. Br J Surg, 88, 1241-4.   DOI   ScienceOn
26 Sugitani I, Kasai N, Fujimoto Y ,Yanagisawa A (2004). A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135, 139-48.   DOI   ScienceOn
27 Turanli S (2007). Is the type of dissection in lateral neck metastasis for differentiated thyroid carcinoma important? Otolaryngol Head Neck Surg, 136, 957-60.   DOI   ScienceOn
28 White ML, Gauger PG, Doherty GM (2007). Central lymph node dissection in differentiated thyroid cancer. World J Surg, 31, 895-904.   DOI   ScienceOn